Familial Pulmonary Fibrosis research hub

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

This study investigates if a new drug, nerandomilast, can slow down lung changes in people aged 40+ with a family history of lung scarring (pulmonary fibrosis) and early changes seen on a lung scan. Participants receive either the drug or a dummy pill.